233 related articles for article (PubMed ID: 23484635)
21. Impact of Systemic Chemotherapy and Delayed Enucleation on Survival of Children with Advanced Intraocular Retinoblastoma.
Zhao J; Feng ZX; Wei M; Liu G; Solarte CE; Li B; Wang Y; Zhang C; Gallie BL
Ophthalmol Retina; 2020 Jun; 4(6):630-639. PubMed ID: 32387053
[TBL] [Abstract][Full Text] [Related]
22. Retinoblastoma.
Melamud A; Palekar R; Singh A
Am Fam Physician; 2006 Mar; 73(6):1039-44. PubMed ID: 16570739
[TBL] [Abstract][Full Text] [Related]
23. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
[TBL] [Abstract][Full Text] [Related]
24. Examinations under anaesthesia as a measure of disease burden in unilateral retinoblastoma: the London experience.
Fabian ID; Shah V; Kapelushnik N; Naeem Z; Onadim Z; Price E; Chowdhury T; Duncan C; Stansfield D; Sagoo M; Reddy MA
Br J Ophthalmol; 2020 Jan; 104(1):17-22. PubMed ID: 30862620
[TBL] [Abstract][Full Text] [Related]
25. Ewing's sarcoma as second malignant neoplasm after retinoblastoma: a case report.
Mittal R; Al Awadi S; Sahar O; Behbehani AM
Med Princ Pract; 2008; 17(1):84-5. PubMed ID: 18059108
[TBL] [Abstract][Full Text] [Related]
26. Clinical presentation and treatment outcome of retinoblastoma in children of South Western China.
Gao J; Zeng J; Guo B; He W; Chen J; Lu F; Chen D
Medicine (Baltimore); 2016 Oct; 95(42):e5204. PubMed ID: 27759657
[TBL] [Abstract][Full Text] [Related]
27. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
28. Study on clinical therapeutic effect including symptoms, eye preservation rate, and follow-up of 684 children with retinoblastoma.
Huang D; Zhang Y; Zhang W; Wang Y; Zhang P; Hong L; Zhou Y; Han T; Zhi T
Eur J Ophthalmol; 2013; 23(4):532-8. PubMed ID: 23483499
[TBL] [Abstract][Full Text] [Related]
29. How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.
Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Mäusert J; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Lohmann DR; Jöckel KH
J Clin Oncol; 2016 Sep; 34(26):3183-8. PubMed ID: 27382102
[TBL] [Abstract][Full Text] [Related]
30. Clinical manifestations and treatment of retinoblastoma in Korea.
Chung SE; Sa HS; Koo HH; Yoo KH; Sung KW; Ham DI
Br J Ophthalmol; 2008 Sep; 92(9):1180-4. PubMed ID: 18650212
[TBL] [Abstract][Full Text] [Related]
31. Retinoblastoma presenting with orbital cellulitis.
Walinjkar J; Krishnakumar S; Gopal L; Ramesh A; Khetan V
J AAPOS; 2013 Jun; 17(3):282-6. PubMed ID: 23791410
[TBL] [Abstract][Full Text] [Related]
32. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
[TBL] [Abstract][Full Text] [Related]
33. RETINOBLASTOMA IN INDIA: Clinical Presentation and Outcome in 1,457 Patients (2,074 Eyes).
Kaliki S; Patel A; Iram S; Ramappa G; Mohamed A; Palkonda VAR
Retina; 2019 Feb; 39(2):379-391. PubMed ID: 29210937
[TBL] [Abstract][Full Text] [Related]
34. Clinical and epidemiological characteristics of retinoblastoma: correlation with prognosis in a Turkish pediatric oncology center.
Ozdemir H; Tacyildiz N; Unal E; Yavuz G; Ugur H; Gunduz K
Pediatr Hematol Oncol; 2007; 24(3):221-31. PubMed ID: 17454793
[TBL] [Abstract][Full Text] [Related]
35. [The clinical characteristics and prognosis of 92 cases of delayed occurrence of retinoblastoma].
Zhang Y; Zhang WL; Wang YZ; Shi JT; Ma JM; Huang DS; Hu HM; Hong L; Liu AP; Li J
Zhonghua Yan Ke Za Zhi; 2013 Sep; 49(9):812-6. PubMed ID: 24330931
[TBL] [Abstract][Full Text] [Related]
36. A multicentre report from the Mexican Retinoblastoma Group.
Leal-Leal C; Flores-Rojo M; Medina-Sansón A; Cerecedo-Díaz F; Sánchez-Félix S; González-Ramella O; Pérez-Pérez F; Gómez-Martínez R; Quero-Hernández A; Altamirano-Alvarez E; Alejo-González F; Figueroa-Carbajal J; Ellis-Irigoyen A; Tejocote-Romero I; Cervantes-Paz R; Pantoja-Guillén F; Vega-Vega L; Carrete-Ramírez F
Br J Ophthalmol; 2004 Aug; 88(8):1074-7. PubMed ID: 15258028
[TBL] [Abstract][Full Text] [Related]
37. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
[TBL] [Abstract][Full Text] [Related]
38. Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments.
Venturi C; Bracco S; Cerase A; Cioni S; Galluzzi P; Gennari P; Vallone IM; Tinturini R; Vittori C; De Francesco S; Caini M; D'Ambrosio A; Toti P; Renieri A; Hadjistilianou T
Acta Ophthalmol; 2013 Jun; 91(4):335-42. PubMed ID: 22268993
[TBL] [Abstract][Full Text] [Related]
39. [Clinicopathologic features of retinoblastoma and expression of VEGF and Ki-67 after comprehensive treatment].
Xue K; Qian J; Bi YW; Yao YQ; Yuan YF; DA CD
Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):134-41. PubMed ID: 21426843
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological pattern and management of retinoblastoma in Kano, Nigeria.
Abdu L; Malami S
Ann Afr Med; 2011; 10(3):214-9. PubMed ID: 21912005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
